Injection-site and quality-control risk Reported injection-site issues include redness, mild swelling, transient bruising, and occasional sterile abscess
USADA clearly states that there's no legal basis for selling BPC 157 as a drug, food, or dietary supplement, primarily due to safety concerns
Salidroside alleviates renal ischemia-reperfusion injury by inhibiting macrophage pyroptosis through hif signaling
First, in the absence of Albumax and drug, PS exposure of erythrocytes slowly increased over time, both in Ringer solution (24-fold increase after 48 h, p =0.0011) and in iRPMI (6.4-fold increase after 48 h, p =0.0068)
Adverse reactions to drugs Medicines guidance (BNF)